CN107383033A - 顺式5‑叔丁氧羰基‑四氢呋喃并[3,4‑c]吡咯‑3A‑羧酸甲酯的合成方法 - Google Patents
顺式5‑叔丁氧羰基‑四氢呋喃并[3,4‑c]吡咯‑3A‑羧酸甲酯的合成方法 Download PDFInfo
- Publication number
- CN107383033A CN107383033A CN201710512805.8A CN201710512805A CN107383033A CN 107383033 A CN107383033 A CN 107383033A CN 201710512805 A CN201710512805 A CN 201710512805A CN 107383033 A CN107383033 A CN 107383033A
- Authority
- CN
- China
- Prior art keywords
- compound
- pyrroles
- methyl
- cis
- synthetic method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710512805.8A CN107383033A (zh) | 2017-06-29 | 2017-06-29 | 顺式5‑叔丁氧羰基‑四氢呋喃并[3,4‑c]吡咯‑3A‑羧酸甲酯的合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710512805.8A CN107383033A (zh) | 2017-06-29 | 2017-06-29 | 顺式5‑叔丁氧羰基‑四氢呋喃并[3,4‑c]吡咯‑3A‑羧酸甲酯的合成方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107383033A true CN107383033A (zh) | 2017-11-24 |
Family
ID=60333916
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710512805.8A Pending CN107383033A (zh) | 2017-06-29 | 2017-06-29 | 顺式5‑叔丁氧羰基‑四氢呋喃并[3,4‑c]吡咯‑3A‑羧酸甲酯的合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107383033A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115433194A (zh) * | 2022-09-13 | 2022-12-06 | 上海毕得医药科技股份有限公司 | 一种六氢-3aH-呋喃[2,3-c]吡咯-3a-羧酸甲酯类衍生物的合成方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002046187A1 (en) * | 2000-12-04 | 2002-06-13 | Sepracor, Inc. | Analgesic diazabicyclo[4.3.0]nonanes |
CN101535297A (zh) * | 2006-07-14 | 2009-09-16 | 株式会社Lg生命科学 | 黑皮质素受体激动剂 |
CN102015721A (zh) * | 2008-03-07 | 2011-04-13 | 尼瑞斯药品公司 | Salinosporamide a及其类似物的全合成 |
US20120277305A1 (en) * | 2011-04-29 | 2012-11-01 | Catabasis Pharmaceuticals, Inc. | Fatty acid guanidine and salicylate guanidine derivatives and their uses |
-
2017
- 2017-06-29 CN CN201710512805.8A patent/CN107383033A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002046187A1 (en) * | 2000-12-04 | 2002-06-13 | Sepracor, Inc. | Analgesic diazabicyclo[4.3.0]nonanes |
CN101535297A (zh) * | 2006-07-14 | 2009-09-16 | 株式会社Lg生命科学 | 黑皮质素受体激动剂 |
CN102015721A (zh) * | 2008-03-07 | 2011-04-13 | 尼瑞斯药品公司 | Salinosporamide a及其类似物的全合成 |
US20120277305A1 (en) * | 2011-04-29 | 2012-11-01 | Catabasis Pharmaceuticals, Inc. | Fatty acid guanidine and salicylate guanidine derivatives and their uses |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115433194A (zh) * | 2022-09-13 | 2022-12-06 | 上海毕得医药科技股份有限公司 | 一种六氢-3aH-呋喃[2,3-c]吡咯-3a-羧酸甲酯类衍生物的合成方法 |
CN115433194B (zh) * | 2022-09-13 | 2023-06-23 | 上海毕得医药科技股份有限公司 | 一种六氢-3aH-呋喃[2,3-c]吡咯-3a-羧酸甲酯类衍生物的合成方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2009132673A (ru) | Способы и промежуточные продукты для получения макроциклического ингибитора протеазы вируса гепатита с | |
CN108558692B (zh) | 一种酰胺类化合物的制备方法 | |
CN107312007B (zh) | 2(2-乙氧基-2-氧代乙基)-8-甲基-5,6-二氢咪唑并吡嗪羧酸叔丁酯的制法 | |
CN107915630B (zh) | 一种琥珀酸二酯或琥珀酸二酯衍生物的制备方法 | |
CN106892928B (zh) | 一种叔丁基-8-羟基-5-氧杂-2-氮杂螺环[3.5]壬烷-2-羧酸酯的合成方法 | |
CN107383033A (zh) | 顺式5‑叔丁氧羰基‑四氢呋喃并[3,4‑c]吡咯‑3A‑羧酸甲酯的合成方法 | |
EP2872477B1 (en) | Process for the preparation of ingenol-3-angelate from 20-deoxy-ingenol | |
CN111533745A (zh) | 叔丁基-3-(氨基甲基)二氢-5h-三唑并二氮杂卓-8(9h)-甲酸基酯制法 | |
Ren et al. | A simple procedure for the esterification and transesterification using p-toluene sulfonic acid as catalyst | |
CN111320577B (zh) | 一种吡啶酰胺的制备方法及其应用 | |
CN105418620B (zh) | 一种4-(叔丁氧羰基)八氢呋喃并[3,2-b]吡啶-6-羧酸的合成方法 | |
CN103073480B (zh) | 一种2‑(叔丁氧羰基)八氢环戊[c]吡咯‑5‑羧酸的制备方法 | |
CN103613602B (zh) | 藤黄酸衍生物及其制备方法和应用 | |
CN106674330B (zh) | 一种34-Dimethyl apratoxin A/E的制备方法 | |
CN111018779B (zh) | 一种2-(3-异喹啉基)-丙酸乙酯衍生物及合成方法 | |
CN108239019A (zh) | 一种(2s,5s或5r)-n-叔丁氧羰基-5-羟基-2-哌啶甲酸乙酯的合成方法 | |
CN103547558B (zh) | 制备含五元环化合物的方法 | |
CN107089957B (zh) | 一种4h-5-(1-羟基-1-甲基乙基)-2-甲基-2-呋喃乙醇的制备方法 | |
CN107188891A (zh) | 一种5‑(叔丁基羰基)‑1‑甲基‑咪唑并吡啶‑7‑羧酸的合成方法 | |
CN107163049B (zh) | 一种恩替卡韦的制备方法 | |
CN111606905B (zh) | 二叔丁基-2-(2-乙氧基-2-氧亚基乙基)二氢-3h-咪唑并吡啶二甲酸基酯制法 | |
CN105693727B (zh) | 8-(叔丁氧羰基)-6,7,8,9-四氢-5-氢-咪唑[1,5-a][1,4]二氮杂-6-羧酸的合成方法 | |
CN111574524B (zh) | 2-(叔丁氧基羰基)-7-氧亚基-2,6-二氮杂螺[3.4]辛烷-5-羧酸制法 | |
CN111285846B (zh) | 一种2-(2-吲哚基)-乙酸酯衍生物及其合成方法 | |
CN109503593A (zh) | 5-叔丁氧羰基-2-氧亚基八氢吡咯并[3,4-b]吡咯-3a-羧酸的制法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 200131 No. 288 Fu Tai Road, Waigaoqiao Free Trade Zone, Pudong New Area, Shanghai Applicant after: Shanghai Yaoming Kangde New Medicine Development Co., Ltd. Applicant after: Tianjin Yaoming Kangde New Medicine Development Co., Ltd. Applicant after: Wuhan AppTec New Drug Development Co., Ltd. Applicant after: Wuxi Yaoming Biotechnology Co., Ltd. Applicant after: Wuxi Hequan Pharmaceutical Co., Ltd. Address before: 200131 No. 288 Fu Tai Road, Waigaoqiao Free Trade Zone, Pudong New Area, Shanghai Applicant before: Shanghai Yaoming Kangde New Medicine Development Co., Ltd. Applicant before: Tianjin Yaoming Kangde New Medicine Development Co., Ltd. Applicant before: Wuhan AppTec New Drug Development Co., Ltd. Applicant before: WUXI APPTEC BIOPHARMACEUTICALS CO., LTD. Applicant before: Wuxi Wuxi Pharmaceutical Co. Ltd. |
|
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20171124 |